NCT00002059View on ClinicalTrials.gov

A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Inosine pranobex

Trial Locations (1)

92656

Newport Pharmaceuticals International Inc, Laguna Hills

Sponsors
All Listed Sponsors
lead

Newport Pharmaceuticals International

INDUSTRY

NCT00002059 - A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers | Biotech Hunter | Biotech Hunter